Agenda - 4th meeting of the HTA Network (Brussels, 23 March 2015)
Meeting documents
EFPIA Avoiding duplication – using European reports in national processes
Andreas Rappagliosi
Co-Chair of the EFPIA HTA Task Force
HTA Network Working Group - Process, aims and content of Draft Reflection paper on“Reuse of Joint Work in national HTA activities
François Meyer
Advisor to the President of Haute Autorité de Santé , France
Mirjana Huic
Assistant Director and Head of HTA Department, Agency for Quality and Accreditation in Health Care and Social Welfare, Croatia
Health Technology Assessment in Ireland
Dr Mairin Ryan
Director of Health Technology Assessment, Health Information and Quality Authority, Ireland
Mapping HTA structures and processes in the Member States
HTA Network Secretariat
Collaboration of Assessments of Medical Devices Chances & Challenges: The Austrian Perspective
Dr. Claudia Wild
Director of Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
HTA for Medical Devices -expectations and limits of the EU cooperation on HTA, the view of med tech Industry
Mr. Serge Bernasconi
CEO Eucomed and CEO EDMA, members of MedTech Europe
Dr. Geoff Wilson
COCIR HTA Task Force Leadership
Revision of the medical devices legislation
Sabine Lecrenier
Head of Unit, Health Technologies and Cosmetics, European Commission - DG GROW
Safe and Timely Access to Medicines for Patients (STAMP) EC Expert Group
Olga Solomon
Deputy Head of Unit, Medicinal Products -Authorisations, European Medicines Agency, European Commission - DG SANTE
Innovative Medicines Initiative (IMI) projects relevant for HTA
Nathalie Seigneuret
Senior Scientific Project Manager, IMI
Einzelheiten
- Datum der Veröffentlichung
- 24 Februar 2015
- Autor
- Generaldirektion Gesundheit und Lebensmittelsicherheit